Seattle-based KenSci develops software designed to help healthcare organizations predict which of their patients are most likely to get sick. Image courtesy of KenSci.
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars